Clinical trial Recruiting at 1 site Observational Ages 18 and up

Monitoring molecular changes after kidney transplantation

Official title: Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation

Run by Odense University Hospital · NCT01515605 · Data updated 2026-11-12

This study is testing if checking blood and tissue samples can help doctors spot problems early and improve outcomes for people who have received a kidney transplant.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorOdense University Hospital
Academic / other
Locations1 site (Odense, DK)
StatusRecruiting
StartedJanuary 1, 2011
Main results expectedMarch 31, 2033
Study endsMarch 31, 2033
Registry record updatedMarch 28, 2023
Trial IDNCT01515605 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals who have recently undergone kidney transplantation and can provide informed consent.

Probably not a fit

Patients who are unable to provide informed consent or have not undergone kidney transplantation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the molecular monitoring of patients who have undergone kidney transplantation. It evaluates blood, plasma, urine, and tissue samples to assess the effectiveness of noninvasive diagnostic techniques in improving transplant outcomes. The study involves routine clinical and laboratory data collection at various time points post-transplantation, analyzing gene transcripts and conducting proteomic analyses. The goal is to identify biomarkers that could indicate the success of the transplant and potential complications.

Why it matters

Potential benefit: If successful, this approach could lead to better management and outcomes for kidney transplant recipients.

How similar studies have gone: Other studies have shown promise in using molecular monitoring techniques for transplant patients, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients after kidney transplantation, male, female, informed consent

Exclusion Criteria:

* Deny of informed consent

Where it's running

  • Odense University Hospital
    Odense, Dk, Denmark
    Recruiting

Study contacts

  • Principal investigator: Martin Tepel, Dr — Odense University Hospital

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.